Clinical Trials Browser

Phase 2 × Advanced Squamous Non-Small-Cell Lung Cancer × tislelizumab × Clear all

NCT05900921 2023-06-13

Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer

Phase 2 Unknown

Advanced Squamous Non-Small-Cell Lung Cancer